Tilmacoxib
From Wikipedia the free encyclopedia
![]() | |
![]() | |
Pharmacokinetic data | |
---|---|
Bioavailability | solution (64–88%) compared with capsule (22–40%). |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H19FN2O3S |
Molar mass | 338.40 g·mol−1 |
3D model (JSmol) | |
| |
|
Tilmacoxib or JTE-522 is a COX-2 inhibitor and is an effective chemopreventive agent against rat experimental liver fibrosis.[1]
See also[edit]
References[edit]
- ^ Yamamoto H, Kondo M, Nakamori S, Nagano H, Wakasa K, Sugita Y, et al. (August 2003). "JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1". Gastroenterology. 125 (2): 556–71. doi:10.1016/s0016-5085(03)00904-1. PMID 12891558.